Clinical and genetic heterogeneity in myotonic dystrophies

Muscle Nerve. 2000 Dec;23(12):1789-99. doi: 10.1002/1097-4598(200012)23:12<1789::aid-mus2>3.0.co;2-4.

Abstract

This review of myotonic dystrophies primarily concentrates on the clinical and genetic findings that can distinguish a novel form of myotonic dystrophy, myotonic dystrophy type 2 (DM2); proximal myotonic myopathy (PROMM); and proximal myotonic dystrophy (PDM) from myotonic dystrophy type 1 (DM1). The multisystemic nature of these disorders leads to a spectrum of symptoms and signs. Careful clinical evaluation of patients with DM2/PROMM shows that the similarities among the multisystemic myotonic disorders outweigh the differences. An important point in the comparison of the phenotypes of DM1 and DM2/PROMM is that no severe congenital type of DM2/PROMM has yet been described. Genetic linkage analyses show that myotonic dystrophies can be divided into three types: the conventional Steinert type linked to chromosome 19q13.3 (DM1); DM2/PROMM and PDM linked to chromosome 3q21.3; and families not linked to either chromosomal site. Although the diagnosis may be clinically suspected, it depends on DNA analysis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Chromosome Mapping*
  • Chromosomes, Human, Pair 19
  • Chromosomes, Human, Pair 3
  • Diagnosis, Differential
  • Humans
  • Myotonic Dystrophy / classification
  • Myotonic Dystrophy / genetics*
  • Myotonic Dystrophy / physiopathology*